Latest Breaking News On - Priveterra acquisition corp - Page 1 : comparemela.com

Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why - AEON Biopharma (AMEX:AEON)

Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over placebo. Despite anticipated reductions in monthly migraine days, statistical significance was not reached, prompting a review of development strategies and financial measures.

Biopharma incPriveterra acquisition corpMarc forth

Priveterra Acquisition Corp II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Priveterra Acquisition Corp. II today announced that on April 29, 2024, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC.

Securities exchangeNasdaq listing qualifications departmentNasdaq stock marketExchange commission onNasdaq hearings panel thePriveterra acquisition corpCompany formPriveterra acquisitionNasdaq listing qualificationsAnnual reportNasdaq listing rulesNasdaq hearings panelNasdaq capital marketExchange commissionSecurities actSecurities exchange act

AEON Biopharma (AEON) Files for Share and Warrant Offering

AEON Biopharma (AEON) Files for Share and Warrant Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesPriveterra acquisition corpBusiness combinationCommon stockNew moneyConvertible notesRound lot holder subscription agreementsPriveterra acquisitionPriveterra classPrivate placementPublic warrantsPublic warrantYork cityRedemption noticeRedemption date

Short Interest in Priveterra Acquisition Corp II (NASDAQ:PMGMW) Declines By 27 9%

Priveterra Acquisition Corp. II (NASDAQ:PMGMW – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 18,600 shares, a decline of 27.9% from the February 29th total of 25,800 shares. Based on an average daily trading volume, of 10,700 shares, the days-to-cover ratio is […]

News ratings for priveterra acquisition corpAristeia capitalShaolin capital managementPriveterra acquisition corpIi company profilePriveterra acquisitionGet free reportCapital managementPriveterra acquisition corp iiNasdaq pmgmwFinancial service

AEON Biopharma (AEON) Announces Share and Warrant Offering by Selling Stockholders

AEON Biopharma (AEON) Announces Share and Warrant Offering by Selling Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Priveterra acquisition corpBusiness combinationCommon stockNew moneyForward purchase agreementsRound lot holder subscription agreementsPriveterra acquisitionPriveterra classPrivate placement